Reduction of leukemic burden via bone‐targeted nanoparticle delivery of an inhibitor of C‐chemokine (C‐C motif) ligand 3 (CCL3) signaling-Reference-Cited by-同舟云学术

Reduction of leukemic burden via bone‐targeted nanoparticle delivery of an inhibitor of C‐chemokine (C‐C motif) ligand 3 (CCL3) signaling

Author:

Ackun‐Farmmer Marian A.¹²,Soto Celia A.³,Lesch Maggie L.³,Byun Daniel²,Yang Lila⁴,Calvi Laura M.²⁵⁶,Benoit Danielle S. W.¹²⁷⁸,Frisch Benjamin J.¹²³⁶

Affiliation:

1. Department of Biomedical Engineering University of Rochester Rochester NY USA

2. Department of Orthopaedics and Center for Musculoskeletal Research University of Rochester Medical Center Rochester NY USA

3. Department of Pathology and Laboratory Medicine University of Rochester Rochester NY USA

4. New York Institute of Technology College of Osteopathic Medicine New York NY USA

5. Department of Medicine Endocrine Division University of Rochester Medical Center Rochester NY USA

6. Wilmot Cancer Institute School of Medicine and Dentistry University of Rochester Rochester NY USA

7. Materials Science Program University of Rochester Rochester NY USA

8. Department of Chemical Engineering University of Rochester Rochester NY USA

Funder

National Cancer Institute

National Institute of Arthritis and Musculoskeletal and Skin Diseases

National Science Foundation

University of Rochester

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

Reference50 articles.

1. Cancer Stat Facts: Acute Myeloid Leukemia (AML)[Internet].NCI ‐ surveillance epidemiology and end results program.2017.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献